Alignment Healthcare, Inc. (ALHC) FinancialsALHCFinancialAlignment Healthcare, Inc.

Evaluating the bottom line, Alignment Healthcare, Inc. maintains a gross margin of 12.96%. This metric reflects the company's pricing power and manufacturing efficiency. Further down the income statement, the operating margin stands at 3.15%, while the net margin is 2.74%. These profitability ratios, combined with a Return on Equity (ROE) of 20.04%, provide a clear picture of how effectively ALHC converts its operational activities into shareholder value.

In the context of the broader market, ALHC competes directly with industry leaders such as OSCR and MOH. With a market capitalization of $2.90B, it holds a significant position in the sector. When comparing efficiency, ALHC's gross margin of 12.96% stands against OSCR's N/A and MOH's 12.82%. Such benchmarking helps identify whether Alignment Healthcare, Inc. is trading at a premium or discount relative to its financial performance.

The company reported a Q2 EPS of $0.17, beating expectations, but revenue of $1.3 billion fell short by $10 million. The gross margin improved to 12.96% in Q2 2026, showing progress in profitability.